#AUA14 - Poster: An indirect treatment comparison and cost-effectiveness analysis of abiraterone acetate and enzalutamide for the treatment of metastatic castration-resistant prostate cancer post chemotherapy

ORLANDO, FL USA (UroToday.com) - Presented by Melissa Thompson,1 Tracy Li,2 Mary B. Todd,2 Margaret K. Yu,4 Thian Kheoh,3 Jianming He,2 and Ryan Saadi2 at the American Urological Association (AUA) Annual Meeting - May 16 - 21, 2014 - Orlando, Florida USA

aua 2014 aa thompson poster thumb

1Cornerstone Research Group, Inc., Burlington, ON, Canada
2Janssen Global Services, LLC, Raritan, NJ USA
3Janssen Research & Development, Los Angeles, CA USA

Click HERE to read an exclusive report by a UroToday medical writer

 

 

email news signup